Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daleke-Schermerhorn MH"'
Autor:
Schetters STT; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Jong WSP; Abera Bioscience AB, Stockholm, Sweden., Horrevorts SK; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Kruijssen LJW; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Engels S; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Stolk D; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Daleke-Schermerhorn MH; Abera Bioscience AB, Stockholm, Sweden; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Science, VU University, Amsterdam, The Netherlands., Garcia-Vallejo J; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Houben D; Abera Bioscience AB, Stockholm, Sweden; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Science, VU University, Amsterdam, The Netherlands., Unger WWJ; Laboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., den Haan JMM; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Luirink J; Abera Bioscience AB, Stockholm, Sweden; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Science, VU University, Amsterdam, The Netherlands., van Kooyk Y; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands. Electronic address: y.vankooyk@vumc.nl.
Publikováno v:
Acta biomaterialia [Acta Biomater] 2019 Jun; Vol. 91, pp. 248-257. Date of Electronic Publication: 2019 Apr 17.
Autor:
Kuipers K; Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Daleke-Schermerhorn MH; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands; Abera Bioscience AB, Stockholm, Sweden., Jong WS; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands; Abera Bioscience AB, Stockholm, Sweden., ten Hagen-Jongman CM; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands; Abera Bioscience AB, Stockholm, Sweden., van Opzeeland F; Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Simonetti E; Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Luirink J; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands; Abera Bioscience AB, Stockholm, Sweden. Electronic address: s.luirink@vu.nl., de Jonge MI; Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: marien.dejonge@radboudumc.nl.
Publikováno v:
Vaccine [Vaccine] 2015 Apr 21; Vol. 33 (17), pp. 2022-9. Date of Electronic Publication: 2015 Mar 14.
Autor:
Jong WS; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Earth and Life Sciences, VU University, De Boelelaan 1085, 1081, HV, Amsterdam, The Netherlands. w.s.p.jong@vu.nl.; Abera Bioscience AB, SE-111 45, Stockholm, Sweden. w.s.p.jong@vu.nl., Daleke-Schermerhorn MH; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Earth and Life Sciences, VU University, De Boelelaan 1085, 1081, HV, Amsterdam, The Netherlands. maria.daleke@aberabio.com.; Abera Bioscience AB, SE-111 45, Stockholm, Sweden. maria.daleke@aberabio.com., Vikström D; Xbrane Bioscience AB, SE-111 45, Stockholm, Sweden. david.vikstrom@xbrane.com.; Department of Biochemistry and Biophysics, Center for Biomembrane Research, Stockholm University, SE-106 91, Stockholm, Sweden. david.vikstrom@xbrane.com., Ten Hagen-Jongman CM; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Earth and Life Sciences, VU University, De Boelelaan 1085, 1081, HV, Amsterdam, The Netherlands. c.m.ten.hagen-jongman@vu.nl.; Abera Bioscience AB, SE-111 45, Stockholm, Sweden. c.m.ten.hagen-jongman@vu.nl., de Punder K; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066, CX, Amsterdam, The Netherlands. karin.de-punder@charite.de.; Present Address: Institute for Medical Psychology, Charité Universitätsmedizin, 10117, Berlin, Germany. karin.de-punder@charite.de., van der Wel NN; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066, CX, Amsterdam, The Netherlands. N.N.vanderWel@amc.uva.nl.; Present Address: Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, 1105, AZ, Amsterdam, The Netherlands. N.N.vanderWel@amc.uva.nl., van de Sandt CE; Department of Viroscience, Erasmus Medical Center, 3015, GE, Rotterdam, The Netherlands. c.vandesandt@erasmusmc.nl., Rimmelzwaan GF; Department of Viroscience, Erasmus Medical Center, 3015, GE, Rotterdam, The Netherlands. g.rimmelzwaan@erasmusmc.nl., Follmann F; Department of Infectious Disease & Immunology, Statens Serum Institut, Copenhagen, Denmark. FRF@ssi.dk., Agger EM; Department of Infectious Disease & Immunology, Statens Serum Institut, Copenhagen, Denmark. EAG@ssi.dk., Andersen P; Department of Infectious Disease & Immunology, Statens Serum Institut, Copenhagen, Denmark. PA@ssi.dk., de Gier JW; Xbrane Bioscience AB, SE-111 45, Stockholm, Sweden. degier@dbb.su.se.; Department of Biochemistry and Biophysics, Center for Biomembrane Research, Stockholm University, SE-106 91, Stockholm, Sweden. degier@dbb.su.se., Luirink J; Department of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Earth and Life Sciences, VU University, De Boelelaan 1085, 1081, HV, Amsterdam, The Netherlands. s.luirink@vu.nl.; Abera Bioscience AB, SE-111 45, Stockholm, Sweden. s.luirink@vu.nl.
Publikováno v:
Microbial cell factories [Microb Cell Fact] 2014 Nov 25; Vol. 13, pp. 162. Date of Electronic Publication: 2014 Nov 25.
Autor:
Daleke-Schermerhorn MH; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands Abera Bioscience AB, Stockholm, Sweden maria.daleke@aberabio.com s.luirink@vu.nl., Felix T; Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris, France INSERM, U1041, Paris, France., Soprova Z; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands., Ten Hagen-Jongman CM; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands Abera Bioscience AB, Stockholm, Sweden., Vikström D; Center for Biomembrane Research, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden Xbrane Bioscience AB, Stockholm, Sweden., Majlessi L; Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris, France INSERM, U1041, Paris, France., Beskers J; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands., Follmann F; Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., de Punder K; The Netherlands Cancer Institute, Antonie van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van der Wel NN; The Netherlands Cancer Institute, Antonie van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Baumgarten T; Center for Biomembrane Research, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden., Pham TV; Department of Medical Oncology, OncoProteomics Laboratory, VU University Medical Center, Amsterdam, The Netherlands., Piersma SR; Department of Medical Oncology, OncoProteomics Laboratory, VU University Medical Center, Amsterdam, The Netherlands., Jiménez CR; Department of Medical Oncology, OncoProteomics Laboratory, VU University Medical Center, Amsterdam, The Netherlands., van Ulsen P; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands., de Gier JW; Center for Biomembrane Research, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden., Leclerc C; Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Paris, France INSERM, U1041, Paris, France., Jong WS; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands Abera Bioscience AB, Stockholm, Sweden., Luirink J; Section Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands Abera Bioscience AB, Stockholm, Sweden maria.daleke@aberabio.com s.luirink@vu.nl.
Publikováno v:
Applied and environmental microbiology [Appl Environ Microbiol] 2014 Sep; Vol. 80 (18), pp. 5854-65. Date of Electronic Publication: 2014 Jul 18.
Autor:
van Ulsen P; Section of Molecular Microbiology, Department of Molecular Cell Biology, VU University, 1081 HV Amsterdam, The Netherlands. Electronic address: j.p.van.ulsen@vu.nl., Rahman Su; Section of Molecular Microbiology, Department of Molecular Cell Biology, VU University, 1081 HV Amsterdam, The Netherlands., Jong WS; Section of Molecular Microbiology, Department of Molecular Cell Biology, VU University, 1081 HV Amsterdam, The Netherlands; Abera Bioscience AB, SE-111 45 Stockholm, Sweden., Daleke-Schermerhorn MH; Section of Molecular Microbiology, Department of Molecular Cell Biology, VU University, 1081 HV Amsterdam, The Netherlands; Abera Bioscience AB, SE-111 45 Stockholm, Sweden., Luirink J; Section of Molecular Microbiology, Department of Molecular Cell Biology, VU University, 1081 HV Amsterdam, The Netherlands; Abera Bioscience AB, SE-111 45 Stockholm, Sweden. Electronic address: s.luirink@vu.nl.
Publikováno v:
Biochimica et biophysica acta [Biochim Biophys Acta] 2014 Aug; Vol. 1843 (8), pp. 1592-611. Date of Electronic Publication: 2013 Nov 22.